date:Jun 27, 2013
unner in bioyield enhancers, and this acquisition will further underpin Novozymes position with complementary and capable products, while strengthening commercial access, says Thomas Videbk, Executive Vice President of Novozymes and head of Business Development. Combining our existing products and leading global name with TJ Technologies strong and proven portfolio, brands and regional market coverage, will strengthen Novozymes commercial position in important crop markets.
The financial terms